Results 221 to 230 of about 11,649,511 (362)

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Health Promotion Opportunities for Lesbian, Gay and Bisexual People: Using Data From the New Zealand Health Survey. [PDF]

Health Promot J Austr
Adams J, Jankhotkaew J, Ellis SJ, Neville S.   +3 more
europepmc   +1 more source

Proceedings Relating to the Organization of the National Drug Trade Conference [PDF]

, 1913
C. M. Woodruff
openalex   +1 more source

Understanding and measuring mechanical signals in the tumor stroma

FEBS Open Bio, EarlyView.
This review discusses cancer‐associated fibroblast subtypes and their functions, particularly in relation to extracellular matrix production, as well as the development of 3D models to study tumor stroma mechanics in vitro. Several quantitative techniques to measure tissue mechanical properties are also described, to emphasize the diagnostic and ...
Fàtima de la Jara Ortiz, Chiara Cimmino, Maurizio Ventre, Alessandra Cambi   +3 more
wiley   +1 more source

Revisiting the Gateway Drug Hypothesis for Cannabis: A Secondary Analysis of a Nationwide Survey Among Community Users in Japan. [PDF]

Neuropsychopharmacol Rep
Masataka Y, Katayama M, Umemura F, Sugiyama T, Miki N, Akahoshi Y, Oka C, Asahi T, Matsumori T, Takumi I, Murata H, Matsumoto T.   +11 more
europepmc   +1 more source

Observations on the Reactions of the Larvae of Ancylostoma canium and Ancylostoma braziliense to Various Drugs and Chemical Compounds Based on In Vitro Tests

, 1953
EARL B. RITCHIE, William C. King
openalex   +1 more source

The price of innovation: new estimates of drug development costs.

Journal of Health Economics, 2003
J. DiMasi, R. W. Hansen, H. Grabowski
semanticscholar   +1 more source

Bioengineering facets of the tumor microenvironment in 3D tumor models: insights into cellular, biophysical and biochemical interactions

FEBS Open Bio, EarlyView.
The tumor microenvironment is a dynamic, multifaceted complex system of interdependent cellular, biochemical, and biophysical components. Three‐dimensional in vitro models of the tumor microenvironment enable a better understanding of these interactions and their impact on cancer progression and therapeutic resistance.
Salma T. Rafik, Deniz Bakkalci, Alexander J. MacRobert, Umber Cheema   +3 more
wiley   +1 more source

A statistical framework for detecting therapy-induced resistance from drug screens. [PDF]

NPJ Syst Biol Appl
Wu C, Gunnarsson EB, Foo J, Leder K.
europepmc   +1 more source

The Administration of the Federal Food and Drugs Act

, 1933
Lauffer T. Hayes, Frank Ruff
openalex   +2 more sources